Related Experiment Video
Updated: Feb 3, 2026

10:47
Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
16.2K
The Pneumococcal Surface Proteins PspA and PspC Sequester Host C4-Binding Protein To Inactivate Complement C4b on the
Kashif S Haleem1,2, Youssif M Ali1,3, Hasan Yesilkaya1
1Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
Infection and Immunity
|October 17, 2018
Summary
Streptococcus pneumoniae uses PspA and PspC proteins to bind complement regulator C4BP, preventing complement attack. This mechanism inactivates C4b, a key component in bacterial defense evasion.
Area of Science:
- Immunology
- Microbiology
- Bacterial Pathogenesis
Background:
- Complement system is crucial for antimicrobial immunity.
- Pathogens evade complement by sequestering host complement regulators.
- Streptococcus pneumoniae utilizes virulence factors to evade immune attack.
Purpose of the Study:
- Investigate the mechanism of complement evasion by Streptococcus pneumoniae.
- Determine the role of PspA and PspC in complement regulation.
- Elucidate how pneumococcal virulence factors contribute to immune evasion.
Main Methods:
- Opsonization of S. pneumoniae D39 with human serum.
- Analysis of complement activation products (C4b, iC4b, C4dg) and C4BP deposition.
- Generation of PspA and PspC deletion mutants.
- Infection experiments in mice.
- Binding assays with recombinant PspA and PspC.
Main Results:
- S. pneumoniae D39 rapidly converts surface-bound C4b/iC4b to C4dg, preventing C3 convertase formation.
- PspA and PspC sequester C4b-binding protein (C4BP) from host plasma.
- Deletion of PspA/PspC reduced C4BP and C4dg deposition, increasing C4b/iC4b.
- Loss of PspA/PspC resulted in reduced bacterial pathogenicity in mice.
Conclusions:
- PspA and PspC facilitate S. pneumoniae complement evasion by binding C4BP.
- This binding inactivates C4b, preventing complement-mediated bacterial killing.
- PspA and PspC are key virulence factors contributing to pneumococcal pathogenicity.
Related Concept Videos
Activation and Inactivation of G Proteins
11.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.5K
Cell-surface Signaling
54.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.4K
X-Inactivation
41.8K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
41.8K
C4 Pathway and CAM
49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Protein-protein Interfaces
14.7K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.7K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
559
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
559

